Table 2.
Series | n | Nation | Rate without topical antibiotics (%) | Rate with topical antibiotics (%) | P-value |
---|---|---|---|---|---|
Bhatt et al39 | 4,767 | USA | 0.20 | 0.22 | 0.75 |
Bhavsar et al40 | 8,027 | USA | 0.03 | 0.13 | 0.25 |
Cheung et al44 | 15,895 | Canada | 0.038 | 0.061–0.084 | NR |
Falavarjani et al45 | 5,901 | Iran | 0 | 0.10 | 0.18 |
Park et al47 | 17,332 | Korea | 0.035 | 0 | 0.81 |
Ramel et al49,* | 11,450 | France | 0.2 | 0.03 | 0.024 |
Storey et al41 | 117,171 | USA | 0.032 | 0.049 | NR |
Falavarjani et al46 | 8,037 | Iran | 0 | 0.01 | 0.30 |
Gregori et al43 | 121,285 | USA | 0.02 | 0.013 | 0.38 |
Meredith et al42 | 18,509 | USA | 0.15 | 0.04–0.08 | 0.20 |
Note:
Series reporting significant difference in endophthalmitis rates.
Abbreviation: NR, not reported.